chr19-7553027-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001166111.2(PNPLA6):​c.2288-845A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.51 ( 13568 hom., cov: 18)

Consequence

PNPLA6
NM_001166111.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.147

Publications

2 publications found
Variant links:
Genes affected
PNPLA6 (HGNC:16268): (patatin like phospholipase domain containing 6) This gene encodes a phospholipase that deacetylates intracellular phosphatidylcholine to produce glycerophosphocholine. It is thought to function in neurite outgrowth and process elongation during neuronal differentiation. The protein is anchored to the cytoplasmic face of the endoplasmic reticulum in both neurons and non-neuronal cells. Mutations in this gene result in autosomal recessive spastic paraplegia, and the protein is the target for neurodegeneration induced by organophosphorus compounds and chemical warfare agents. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
PNPLA6 Gene-Disease associations (from GenCC):
  • ataxia-hypogonadism-choroidal dystrophy syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • PNPLA6-related spastic paraplegia with or without ataxia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 39
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • cerebellar ataxia-hypogonadism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Laurence-Moon syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • trichomegaly-retina pigmentary degeneration-dwarfism syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.61 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001166111.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNPLA6
NM_001166114.2
MANE Select
c.2261-848A>G
intron
N/ANP_001159586.1
PNPLA6
NM_001166111.2
c.2288-845A>G
intron
N/ANP_001159583.1
PNPLA6
NM_001166113.1
c.2144-845A>G
intron
N/ANP_001159585.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNPLA6
ENST00000600737.6
TSL:1 MANE Select
c.2261-848A>G
intron
N/AENSP00000473211.1
PNPLA6
ENST00000221249.10
TSL:1
c.2144-845A>G
intron
N/AENSP00000221249.5
PNPLA6
ENST00000450331.7
TSL:1
c.2144-845A>G
intron
N/AENSP00000394348.2

Frequencies

GnomAD3 genomes
AF:
0.512
AC:
60791
AN:
118824
Hom.:
13556
Cov.:
18
show subpopulations
Gnomad AFR
AF:
0.395
Gnomad AMI
AF:
0.727
Gnomad AMR
AF:
0.613
Gnomad ASJ
AF:
0.481
Gnomad EAS
AF:
0.451
Gnomad SAS
AF:
0.630
Gnomad FIN
AF:
0.606
Gnomad MID
AF:
0.504
Gnomad NFE
AF:
0.531
Gnomad OTH
AF:
0.497
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.512
AC:
60830
AN:
118896
Hom.:
13568
Cov.:
18
AF XY:
0.518
AC XY:
29395
AN XY:
56764
show subpopulations
African (AFR)
AF:
0.395
AC:
11216
AN:
28398
American (AMR)
AF:
0.613
AC:
7048
AN:
11496
Ashkenazi Jewish (ASJ)
AF:
0.481
AC:
1399
AN:
2910
East Asian (EAS)
AF:
0.451
AC:
1736
AN:
3846
South Asian (SAS)
AF:
0.631
AC:
2429
AN:
3852
European-Finnish (FIN)
AF:
0.606
AC:
4529
AN:
7468
Middle Eastern (MID)
AF:
0.518
AC:
117
AN:
226
European-Non Finnish (NFE)
AF:
0.531
AC:
30970
AN:
58296
Other (OTH)
AF:
0.495
AC:
771
AN:
1558
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
1573
3146
4720
6293
7866
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
572
1144
1716
2288
2860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.443
Hom.:
8217
Bravo
AF:
0.422
Asia WGS
AF:
0.432
AC:
1493
AN:
3466

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
4.2
DANN
Benign
0.28
PhyloP100
-0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs480208; hg19: chr19-7617913; API